logo-loader
viewHaystack Sciences

Haystack Sciences aims to help biotechs discover new drugs with its nDexer technology

Haystack Sciences CEO Eddie Watts sat down with Proactive at the BIO Investor Forum in San Francisco. 

San Francisco-based, privately-held Haystack is developing methods for drug discovery to help find new cures for difficult-to-treat disorders using its indexer technology.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tonix Pharmaceuticals CEO talks through recent pre-clinical and clinical...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman sat down with Proactive at the BIO CEO & investor Conference in New York. Lederman says the biopharma company had recently unveiled the pre-clinical results of TNX-801, its live virus horsepox vaccine that prevents...

3 hours, 9 minutes ago

2 min read